Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main goal of the project is to characterize the bone marrow immunological milieu and investigate potential treatment defining events of the tumor microenvironment in relapsed and refractory multiple myeloma (RRMM) patients receiving BCMA-targeted therapies.
Epistemonikos ID: 2f497c071dba4bc7f6c221b13205f6e568f15b27
First added on: Oct 17, 2026